James Norris, pictured before ... vision loss after taking semaglutide or tirzepatide, the active ingredients in Ozempic, Wegovy, Mounjaro and Zepbound. Norris at his current weight of 230 pounds ...

Weight-loss jabs such as Ozempic have ... changing what she ate and her overall lifestyle - before losing an additional 20lbs after using Ozempic. 'There's been a lot of talk that I just was ...

Some people have critiqued Ozempic (semaglutide)—a diabetes ... Managing Loose Skin After Weight Loss Sagging skin is largely a cosmetic concern, but a prematurely aged appearance may be a ...

Even after quitting GLP-1 treatments, however, “you’re still getting at least some benefit [with at least 5 percent weight loss], which ... If these early results hold up in replicated trials ...

Introducing Hot Shots, a series that examines how Ozempic and other GLP-1 ... to enhance their ability to promote weight loss. I was so frustrated before—tracking my food and exercise with ...

after the maker of Ozempic and Wegovy, the diabetes and obesity treatments, revealed data showing that its new weight-loss drug candidate showed "superior" results compared with taking nothing ...

“Ozempic personality” isn’t just about weight loss—it’s about the psychological impact of such a dramatic shift. And while it ...

After screening 20,000 protein-encoding genes in the human body, Stanford researchers have identified a naturally occurring ...

after the parent of Ozempic and Wegovy, the diabetes and obesity treatments, revealed data showing that its new weight-loss drug candidate showed "superior" results compared with taking nothing.

Semaglutide may help reduce alcohol cravings and intake, according to a clinical trial. Participants receiving the drug drank ...

Shares of Novo Nordisk slipped in Monday morning trading after the company announced results of its latest weight-loss drug trial ... the company's other drugs, Ozempic, which is approved ...

after the maker of Ozempic and Wegovy, the diabetes and obesity treatments, revealed data showing that its new weight-loss drug candidate showed “superior” results compared with taking nothing ...